POSTED: Wednesday, November 11, 2009 - 1:52pm
UPDATED: Thursday, June 3, 2010 - 11:59pm
A move by the federal government could have more H1N1 vaccine headed your way.
The F.D.A. has approved a supplemental biologics license application for a new H1N1 vaccine made by Glaxo Smith Kline.
The approval allows the company to make flu vaccines for adults that target this year's flu strain.
The Department of Health and Human Services has already placed an order with the drug maker for more than 7,000,000 doses.
Glaxo Smith Kline expects to begin shipping the vaccine in December.